News
- Kim Lab awarded the Research Scholar Grant (RSG) from American Cancer Society starting January 2023!
https://pressroom.cancer.org/ResearchGrants2022
https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/research-scholar-grants.html - We received our NIH-NCI R37 MERIT AWARD for our neuroendocrine tumor research! (2022)
- We received our NIH-NIA funded grant (R03) to study BBB disruption in neurodegenerative disease! (2022)
- Kim Lab Awarded the 2022 MRFBC Pilot Translational Award from MRF (2022)
https://melanoma.org/funded-research/identification-of-angiopoietin-2-tie-signaling-molecules-as-a-predictive-biomarkers-for-ici-resistance-in-melanoma/ - Kim Lab Awarded Investigator Award from Neuroendocrine Research Foundation (2021)
https://netrf.org/research/targeting-angiopoietin-2-to-improve-ici-therapy-efficacy-in-pnet-metastasis/ - Kim Lab Awarded Taub Institute Grants for Emerging Research (TIGER) (2021)
- Kim Lab Awarded Velocity Award (2020)
https://www.cancer.columbia.edu/news/cancer-researchers-win-seed-funding-velocity - Kim Lab Awarded NETRF Pilot Award (2019)
https://netrf.org/2020/02/10/netrf-awards-3-5-million-in-grants/
https://netrf.org/research/angiopoietin-2-tie2-signaling-regulation-of-liver-metastasis-in-pnets/